ArticleBMC neurology2026
Favorable seizure control with a gluten-free diet in a patient with drug-resistant epilepsy and celiac disease: a case report.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCeliac disease (CD) is a chronic autoimmune disorder triggered by gluten sensitivity. Beyond its gastrointestinal presentation, CD is increasingly associated with neurological manifestations, including epilepsy. CASE PRESENTATION: To report the case of a 21-year-old female with a 15-year history of medically resistant epilepsy. Despite multiple antiseizure medications, seizure control remained inadequate. Further evaluation led to a diagnosis of biopsy-confirmed CD. The patient was initiated on a strict gluten-free diet, which resulted in significant clinical improvement and better seizure control. The ethnicity of the patient is Arab-berber (Maghrebi).
conclusionThis case highlights the importance of considering CD in the differential diagnosis of medically resistant epilepsy. Early recognition and dietary management may improve neurological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.